4.76
+0.18(+3.93%)
Currency In USD
| Previous Close | 4.58 |
| Open | 4.58 |
| Day High | 4.87 |
| Day Low | 4.55 |
| 52-Week High | 6.55 |
| 52-Week Low | 1.26 |
| Volume | 2.23M |
| Average Volume | 4.16M |
| Market Cap | 1.27B |
| PE | -4.96 |
| EPS | -0.96 |
| Moving Average 50 Days | 4.32 |
| Moving Average 200 Days | 3.49 |
| Change | 0.18 |
If you invested $1000 in Sana Biotechnology, Inc. (SANA) since IPO date, it would be worth $135.61 as of January 22, 2026 at a share price of $4.76. Whereas If you bought $1000 worth of Sana Biotechnology, Inc. (SANA) shares 3 years ago, it would be worth $1,034.78 as of January 22, 2026 at a share price of $4.76.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Sana Biotechnology to Present at the 44th Annual J.P. Morgan Healthcare Conference
GlobeNewswire Inc.
Jan 07, 2026 9:26 PM GMT
SEATTLE, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it will webcast its presentation at the 44th Annual J.P. Morg
Sana Biotechnology Announces Publication in Nature Biotechnology of in vivo Gene Editing of Human Hematopoietic Stem Cells in Preclinical Models Using the Fusogen Platform
GlobeNewswire Inc.
Dec 08, 2025 2:00 PM GMT
Data Demonstrate Potent in vivo Gene Editing of Hematopoietic Stem Cells (HSCs) in the Bone Marrow with Systemic Delivery in Preclinical Murine Models Using Fusogen Technology Broadens Application of Fusogen Technology Beyond T Cells to Second Cell
Sana Biotechnology to Present at December 2025 Investor Conferences
GlobeNewswire Inc.
Nov 24, 2025 9:05 PM GMT
SEATTLE, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it will webcast its presentations at two investor conferences